Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Katangolo's Profile
Displaying 351-400 of 558 result(s).
CYDY CytoDyn Inc
11/22/2024 2:12:09 PM
This happened to me two years ago a
CYDY CytoDyn Inc
11/22/2024 10:35:21 AM
Good for you! Ghost, the 13-D’er (3)
CYDY CytoDyn Inc
11/22/2024 10:16:54 AM
Got more at $11.1¢. These Short At (3)
CYDY CytoDyn Inc
11/19/2024 4:08:04 PM
700k shares were Rangebound by 0.02 (6)
CYDY CytoDyn Inc
11/18/2024 8:04:32 PM
Thanks For sharing. I didn’t see (1)
CYDY CytoDyn Inc
11/18/2024 4:10:13 PM
That happened to me last week the f (2)
CYDY CytoDyn Inc
11/04/2024 1:47:27 PM
I think so too. Today’s attack di (3)
CYDY CytoDyn Inc
11/04/2024 12:17:23 PM
Interesting that RES, LL, and the G (5)
CYDY CytoDyn Inc
11/04/2024 12:11:24 PM
An article describing the complemen (5)
CYDY CytoDyn Inc
11/01/2024 12:00:51 PM
Looking more and more likely that t (13)
CYDY CytoDyn Inc
10/30/2024 9:01:43 AM
“And a GLP-1 agonist”- talk abo (9)
CYDY CytoDyn Inc
10/26/2024 1:05:57 PM
Amazing dialogue. Lots of highlight (3)
CYDY CytoDyn Inc
10/23/2024 10:13:29 PM
I remember these studies with Alpri (2)
CYDY CytoDyn Inc
10/23/2024 6:40:09 PM
I saw a post on Reddit (sunraydoc) (31)
CYDY CytoDyn Inc
10/22/2024 7:35:15 PM
Good find. I don’t doubt you are (16)
CYDY CytoDyn Inc
10/21/2024 8:56:16 PM
Maraviroc made a splash when it fir (21)
CYDY CytoDyn Inc
10/21/2024 7:54:00 PM
Interesting find. Thank you. (4)
CYDY CytoDyn Inc
10/21/2024 7:28:34 PM
Can you please provide a link showi (2)
CYDY CytoDyn Inc
10/21/2024 1:48:30 PM
If that’s what the partnership ag (2)
CYDY CytoDyn Inc
10/21/2024 12:37:43 AM
I read your latest post over on red (26)
CYDY CytoDyn Inc
10/20/2024 1:59:06 PM
The evolutionary advantage being th (2)
CYDY CytoDyn Inc
10/20/2024 5:00:14 AM
Didn’t see that. Apologies see yo (2)
CYDY CytoDyn Inc
10/20/2024 4:58:28 AM
Thanks, MGK2 So he uses the term ne (4)
CYDY CytoDyn Inc
10/20/2024 4:36:20 AM
Your Knowledge carries this Board, (13)
CYDY CytoDyn Inc
10/20/2024 4:08:59 AM
Never said I was the sharpest tool (3)
CYDY CytoDyn Inc
10/20/2024 4:02:24 AM
Apologies, Ohm. I hadn’t consider (2)
CYDY CytoDyn Inc
10/20/2024 3:50:55 AM
I’m using your math. Yes (1)
CYDY CytoDyn Inc
10/20/2024 3:39:46 AM
Adjunct Therapy? Your List is 90+ d (3)
CYDY CytoDyn Inc
10/20/2024 3:11:50 AM
The rest of the story? I remember w (2)
CYDY CytoDyn Inc
10/20/2024 3:09:55 AM
You get it too
CYDY CytoDyn Inc
10/20/2024 1:21:19 AM
Brilliant as usual,Ohm. Your contri (2)
CYDY CytoDyn Inc
10/20/2024 1:17:55 AM
You get it. (1)
CYDY CytoDyn Inc
10/20/2024 1:15:10 AM
Haven’t watched the video, but ma
CYDY CytoDyn Inc
10/20/2024 1:10:39 AM
And to be clear, this is before the (5)
CYDY CytoDyn Inc
10/20/2024 1:02:18 AM
Neuroscientist’s (me) response he (8)
CYDY CytoDyn Inc
10/20/2024 12:53:40 AM
That’s been a question in The bac (3)
CYDY CytoDyn Inc
10/19/2024 12:12:01 PM
I remember you saying that months a (3)
CYDY CytoDyn Inc
10/17/2024 5:18:44 PM
Prospectus Supplement out https://d (4)
CYDY CytoDyn Inc
10/15/2024 4:48:28 AM
Attention Ohm: Possibly but a decre (1)
CYDY CytoDyn Inc
10/15/2024 4:36:27 AM
Yes, Sir. I saw your post the other (9)
CYDY CytoDyn Inc
10/15/2024 3:29:39 AM
Thank you, Sir. HIV has been my whe (5)
CYDY CytoDyn Inc
10/15/2024 3:24:48 AM
Sorry we were going back-and-forth (1)
CYDY CytoDyn Inc
10/15/2024 3:10:44 AM
OK, well the janssen Component make (2)
CYDY CytoDyn Inc
10/15/2024 2:58:33 AM
Excellent find and thank you for yo (5)
CYDY CytoDyn Inc
10/15/2024 2:31:19 AM
Sorry, forgot the link: https://www (1)
CYDY CytoDyn Inc
10/15/2024 2:29:15 AM
Thank you. I see connections to the (2)
CYDY CytoDyn Inc
10/15/2024 2:19:06 AM
Fostemsavir Isn’t part of the equ (1)
CYDY CytoDyn Inc
10/15/2024 2:08:07 AM
Excellent and thank you. Who owns t (1)
CYDY CytoDyn Inc
10/15/2024 2:06:18 AM
Well, fortunately, your mixup got m (6)
CYDY CytoDyn Inc
10/15/2024 1:39:15 AM
So now you have me thinking. Tradit (11)
Go to page:
  • << First
  • < Previous
  • 7
  • 8
  • Next >

Recent Articles

  • Altoo's Client Survey Reveals Insights on Wealth Platform Usage
  • Understanding the Options Activity Around Booking Holdings
  • APTO Unveils Innovative Dataset to Boost LLM Mathematical Skills
  • Century Communities Celebrates New Home Development Launch
  • Understanding Investment Growth of Axis Capital Over Years
  • Revolutionizing Real-Time AI: StreamNative's New Solutions
  • Alteryx Achieves Leadership Status in Snowflake's Marketing Report
  • Exploring the Revolutionary Features of Tintri's VMstore T7290
  • GrowthLoop's Innovative Marketing Recognition Highlights Progress
  • B2Gnow Surpasses $5 Trillion in Contract Management Value
  • Hevo Data Achieves Notable Recognition in Data Integration Space
  • E Tech Group Unveils New Brand Identity After Acquisition
  • Innovations in Atrial Fibrillation Therapies and Clinical Trials
  • Crédit Agricole S.A. Announces New Share Buyback Initiative
  • ArcelorMittal Successfully Issues €650 Million Notes for Growth
  • New Developments for Fortinet Investors Amid Class Action Risk
  • Engagement Proposals: Insights into Gen Z and Millennial Trends
  • bioAffinity Technologies Successfully Completes Public Offering
  • Enhancing Educator Effectiveness with Eduthings' New Features
  • Child Data Privacy at Risk: 99% of Apps Breach COPPA
  • Marie Brizard Wine & Spirits Reports Half-Year Financial Results
  • Gaming and Leisure Properties Plans Q3 Earnings Call for Investors
  • Insights into IPSEN's Recent Share Buy-back Program
  • Five Star Bank Expands Location to Serve Walnut Creek Community
  • Investors Investigate Slide Insurance Holdings for Potential Issues
  • AB Science Adjusts Timeline for 2025 Financial Report Release
  • Gaming and Leisure Properties Prepares for Q3 Earnings Call
  • Societe Generale SFH Reports Availability of Financial Data
  • Transforming $100 Into a Flourishing Investment in Bloom Energy
  • Shell plc's Recent Share Buyback: Key Insights and Details
  • Examining Inflation: Healthcare and Everyday Essentials Surge
  • AB Science Adjusts Timeline for Half-Year Financial Release
  • Key Insights into Celsius Holdings Stock Performance Today
  • Class Action Alert: Dow Inc. Faces Securities Fraud Lawsuit
  • ExxonMobil's Strategic Innovations Set Stage for Future Growth
  • Netformx Unveils AssetXpert™ for Enhanced Network Solutions
  • Bitcoin Market Analysis: Potential Trends Ahead
  • ShipStation Partners with Veho for Enhanced Delivery Solutions
  • Revolutionizing Commerce: AI-Driven Solutions by commercetools
  • Stanley Black & Decker Set to Share Third Quarter Earnings
  • Integro Bank Partners with ASU to Explore AI Adoption Trends
  • Fernando Tatis Jr. Teams Up with Bruce Bolt for Exclusive Gear
  • BD&J Supports Local Students with Back-to-School Supplies
  • Celebrate Modern Living at Century Communities' New Venue
  • LG's AI Campaign Connects Hearts with Personalized Songs
  • Investing in Vertiv Holdings: What $100 Would Be Today
  • DraftKings and NBCUniversal: A Game-Changing Partnership
  • Understanding Recent Trends for SoFi Technologies Amid Market Movements
  • Die Cut Lids Market Growth Projections to 2034: Insights & Trends
  • DexCom Shareholders Urged to Review Potential Legal Actions
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site